EUDORLIN Extra ibuprofen pain -table, 10 pcs

Instructions for use for EUDORLIN Extra ibuprofen pain -table, 10 pcs

Detailed instructions for EUDORLIN Extra ibuprofen pain -table, 10 pcs

Field of use

• The drug is an anti -inflammatory and pain relieving drug (non -steroidal anti -inflammatory/analgesic, NSAID) with fever -lowering (antipyretic) properties.
• Areas of application of this drug
  • Symptomatic treatment of
    • slight to moderate pain
    • Fever

Active ingredients / ingredients / ingredients

400 mg ibuprofen
Carboxymethylar, sodium salt type a auxiliary substance (+)
Hypromellic auxiliary substance (+)
Macrogol 4000 auxiliary substances (+)
Magnesium stair (Ph. EUR.) [pflanzlich] Hedge substance (+)
Corn starch auxiliary substance (+)
Povidon K30 auxiliary material (+)
Silicium dioxide, high disperser auxiliary substance (+)
Titan dioxide HILDBOFT (+)

Contradictions

• The medicine must not be taken
  • if you are allergic to ibuprofen or one of the other components of this drug
  • in allergic reactions after taking acetylsalicylic acid or other non -steroidal inflammatory inhibitors in the past, such as:
    • Breath of breathing by narrowing the airways (bronchospasm)
    • Asthma attacks
    • Swelling of the nasal mucosa
    • Skin reactions (e.g. reddening, squaddling o. Ä.)
  • in the case of unexplained blood formation disorders
  • in the event of existing or repeated stomach/duodenum ulcers (peptic ulcers) or bleeding (at least 2 different episodes of proven ulcers or bleeding)
  • in the case of gastrointestinal bleeding or breakthrough (perforation) in the history of previous therapy with non-steroidal anti-inflammatory drugs/anti-inflammatory drugs (NSAID)
  • for brain bleeding (cerebrovascular bleeding) or other active bleeding
  • in the case of severe liver or kidney dysfunction
  • in the case of severe heart failure (heart failure)
  • in the last 3 months of pregnancy
• Children
  • The painkillers must not be given to children under the age of 6 or with a body weight of less than 20 kg, since the dose it contains is usually not suitable.

dosage

• Always take this medicine exactly as described here or exactly after the agreement made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.
• Dosage
  • Unless otherwise prescribed by the doctor, the recommended dose is:
    • Body weight (age): 20 kg - 29 kg (6 - 9 years)
      • Single dose: ½ film -coated tablet (corresponding to 200 mg ibuprofen)
      • Maximum daily dose (24 hours): 1½ film -coated tablets (corresponding to 600 mg ibuprofen)
    • Body weight (age): 30 kg - 39 kg (10 - 12 years)
      • Single dose: ½ film -coated tablet (corresponding to 200 mg ibuprofen)
      • Maximum daily dose (24 hours): 2 film -coated tablets (corresponding to 800 mg ibuprofen)
    • Body weight (age): >/= 40 kg (children and adolescents from 12 years and adults)
      • Single dose: ½ - 1 film -coated tablet (corresponding to 200 - 400 mg ibuprofen)
      • Maximum daily dose (24 hours): 3 film -coated tablets (corresponding to 1200 mg ibuprofen)
  • If you have taken the maximum single dose, wait at least 6 hours until the next income.
  • Older people and patients with an earlier stomach or duodenum ulcer
    • These patients should start with the lowest dosage.
  • Limited kidney or liver function
    • If the kidney or liver function is slightly restricted, no dose reduction is inventederlich.
  • Application in children and adolescents
    • If this drug is required for children and adolescents for more than 3 days or if the symptoms worsen, medical advice should be obtained.

 

• Duration of the application
  • Only for a short -term application. Do not apply this medicine to children and adolescents without a medical advice, no longer than 3 days with fever and not for more than 4 days in adults with pain.
  • Please speak to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.

 

• If you have taken a larger amount than you should
  • Take the medicine according to the doctor's instructions or according to the dosage instructions given here. If you have the feeling that you do not feel sufficient pain relief, then do not increase the dosage independently, but ask a doctor.
  • Possible symptoms of an overdose are:
    • central nervous disorders, such as headaches, dizziness, drowsiness and lack of consciousness (also seizures in children)
    • Gastrointestinal complaints such as abdominal pain, nausea and vomiting, bleeding in the gastrointestinal tract
    • Functional disorders of liver and kidneys
    • Blood pressure drop
    • reduced breathing (respiratory depression)
    • blaurot coloring of skin and mucous membranes (cyanosis)
  • There is no specific antidote (antidot).
  • If you suspect an overdose, please notify a doctor immediately. According to the severity of poisoning, this can decide on the measures necessary.

 

• If you have forgotten the intake
  • Do not take the double amount if you have forgotten the prior intake.

 

• If you have any further questions about the application of this medicine, please contact your doctor or pharmacist.

Taking

• Please take the film -coated tablets unscrewed with plenty of liquid (e.g. a glass of water) during or after a meal.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking this medicine.
  • Side effects can be reduced by using the lowest effective dose via the shortest of the period required for symptom control.
  • Before taking this drug, ask a doctor for advice if you have one of the illnesses mentioned below.
  • Security in the gastrointestinal tract
    • A simultaneous use of this drug with other non-steroidal inflammatory inhibitors, including so-called COX-2 inhibitors (cyclooxygenase-2 inhibitors), should be avoided.
    • Older patients
      • In older patients, side effects occur more frequently after using NSAR, in particular bleeding and breakthroughs in the stomach and intestinal area, which may be life-threatening. Therefore, particularly careful medical monitoring is required in older patients.
    • Bleeding of the gastrointestinal tract, ulcers and breakthroughs
      • Bleeding of the gastrointestinal tract, ulcers and breakthroughs (perforations), also with a fatal outcome, were reported during treatment with all NSAIDs. They occurred with or without prior warning symptoms or serious events in the gastrointestinal tract in the prehistory at any time of therapy.
      • The risk of the occurrence of gastrointestinal bleeding, ulcers and breakthroughs is higher with increasing NSAR dose, in patients with ulcers in the history, especially with the complications bleeding or breakthrough, and in older patients. These patients should begin treatment with the lowest available dose. For these patients as well as for patients who accompanying low-dose acetylsalicylic acid (ASA) or other medicines that can increase the risk of gastrointestinal diseases, a combination therapy with gastric mucosa should protect drugs (e.g. misoprostol or proton pump inhibitor).
      • If you have a history of side effects on the gastrointestinal tract, especially at older age, you should report any unusual symptoms in the abdomen (especially gastrointestinal bleeding), especially at the beginning of therapy.
      • Caution is advisable if you get medicines that can increase the risk of ulcers or bleeding, such as: B. Oral corticosteroids, anti-blood clotting medication, such as warfarin, selective serotonin reuptake inhibitors that are used, among other things, to treat depressive moods, or thrombocyte aggregation inhibitors, such as ASS.
      • If you have gastrointestinal bleeding or ulcers during the treatment of the drug, the treatment must be discontinued.
      • In patients with a gastrointestinal disease, NSAR should be used with caution (Colitis Ulcerosa, Crohn's disease) because their condition can deteriorate.
  • Effects on the cardiovascular system
    • Anti -inflammatory agents/painkillers such as ibuprofen can go hand in hand with a slightly increased risk of heart attack or stroke, especially when using in high doses. Do not exceed the recommended dose or duration of treatment.
    • You should discuss your treatment with your doctor or pharmacist before taking this medicine
      • have heart disease including heart failure (heart failure) and angina (chest pain) or a heart attack, a bypass surgery, peripheral arterial cladding disease (circulatory disorders in the legs or feet due to narrowed or closed arteries) or any kind of stroke (including mini stroke or transitory ischemic attack, "tia"),
      • Heavy prints, diabetes or high cholesterol levels or heart diseases or strokes occur in their family history or when they are smokers.
  • Skin reactions
    • Under NSAR therapy, serious skin reactions with redness and bladder formation, some with a fatal outcome, were reported (exfediative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis/lyell syndrome).
    • The highest risk of such reactions seems to exist at the beginning of therapy, since these reactions occurred in the majority of cases in the first month of treatment. At the first sign of rashes, mucosal defects or other signs of a hypersensitivity reaction, this medicine should be discontinued and a doctor should be consulted immediately.
  • Other information
    • This medicine should only be used with the strict weighing of the benefit-risk ratio
      • for certain autoimmune diseases (systemic lupus erythematosus and mixed collagenosis). There is an increased risk of developing symptoms of non-infectious meningitis (aseptic meningitis).
    • A particularly careful medical monitoring is required
      • in the case of gastrointestinal disorders or in chronic inflammatory bowel diseases (ulcerative colitis, Crohn's disease)
      • in the case of high blood pressure or heart failure
      • with limited kidney or liver function
      • directly after larger surgical interventions
      • in allergies (e.g. skin reactions to other medicines, asthma, hay fever), chronic nasal mucosal swelling or chronic, respiratory respiratory diseases narrowing the respiratory tract
    • Severe acute hypersensitivity reactions (e.g. anaphylactic shock) are very rarely observed. At the first sign of a severe hypersensitivity reaction after taking this medicine, you must stop taking it immediately and visit a doctor.
    • Ibuprofen, the active ingredient of this drug, can temporarily inhibit the platelet function (thrombocyte aggregation). Patients with blood clotting disorders should therefore be carefully monitored.
    • If drugs containing ibuprofen at the same time, the anticoagulant effect of low -dose acetylsalicylic acid (prevention of the development of blood clots) can be impaired. In this case you should therefore have ibuprofen-containing medicinesdo not use the egg remedies without express instruction from your doctor.
    • If you are taking on medicinal products at the same time to inhibit blood clotting or to reduce the blood sugar, the blood clotting or blood sugar levels should take place as a precaution.
    • If the drug is permanently durable, regular control of the liver values, the kidney function and the blood count is required.
    • When taking surgical interventions, the doctor or dentist must be questioned or informed.
    • The longer use of all kinds of painkillers against headaches can make them worse. If this is the case or if this is suspected, medical advice should be obtained and treatment can be broken off. The diagnosis of headache in medication overuse (Medication Overuse Headache, MOH) should be assumed in patients who suffer from frequent or daily headaches, although (or precisely because) they regularly take medicines for headaches.
    • In general, the habitual use of pain relievers, especially when combining several pain relieving active ingredients, can lead to permanent kidney damage with the risk of kidney failure (analgesic nephropathy).
    • Use of this drug should be avoided during a chickenpox infection (varicella infection).
  • Children and adolescents
    • There is a risk of kidney dysfunction in dehydrated children and adolescents.

     

• Wateriness and ability to operate machines
  • Since when using this drug in higher dosage, central nervous side effects, such as tiredness and dizziness, can occur, the reaction capacity can be changed in individual cases and the ability to actively participate in road traffic and to operate machines can be impaired. This applies even more in combination with alcohol. You can then no longer react quickly and specifically to unexpected and sudden events. Do not drive a car or other vehicles in this case! Do not operate any tools or machines! Do not work without a safe grip!

   

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • In the first 6 months of pregnancy, you can only use ibuprofen after consultation with your doctor.
  • In the last 3 months of pregnancy, the drug may not be used due to an increased risk of complications for mother and child.
• Reproductive ability
  • The drug may become a group of medicinal products (non -steroidal anti -inflammatory drugs) that can affect the fertility of women. This effect is reversible after stopping the drug (reversible).
• Breastfeeding
  • The active ingredient ibuprofen and its dismantling products only pass into breast milk in small quantities. Since disadvantageous consequences for the infant have not yet become known, breastfeeding is generally not necessary for short -term use. If a longer use or intake of higher doses is prescribed, however, an early wing should be considered.

Hints

Do not apply longer for pain or fever without medical advice than specified in the package insert!

Miscellaneous

- The drug is not suitable for children and adolescents under the age of 14 due to the excessive substance content. - In the case of long-dose, non-determined use of pain relievers, headaches can occur that may not be treated by increased amounts of the druga habitual intake of pain relievers, especially when combining several pain relieving active ingredients, can lead to permanent kidney damage with the risk of kidney failure. a doctor must be informed immediately in the case of visual disturbances, and the medicine must no longer be taken.- If signs of an infection occur or worsen during the use of the drug, a doctor should be appealed immediately. - Since side effects such as tiredness and dizziness can occur when using the drug in higher dosage, the ability to drive a motor vehicle or to use machines can be restricted in individual cases. This applies to an increased extent with simultaneous alcohol consumption. Therapy monitoring:- If the use of longer, regular control of the liver values, kidney function and the blood count is required. - Heavy general hypersensitivity reactions can occur. You can manifest yourself as a facial swelling, swelling of the tongue, inner swelling of the larynx with narrowing of the airways, shortness of breath, hunting heart, a drop in blood pressure and even threatening shock. If one of these phenomena appears that can already occur in the event of an initial application, immediate medical help is required.

Manufacturer:  BERLIN-CHEMIE AG, Glienicker Weg 125, 12489 Berlin